In addition, a 19% decrease in clinical progression per year was observed in a mild-to-moderate AD group following α-tocopherol treatment [77], and consumption of diet-derived vitamin E demonstrated an association with decreased risk of developing AD in individuals without APOE ε4 [78]. The gene discussed is APOE; the disease is Alzheimer disease.